A Single-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3031207 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 16 Apr 2012
At a glance
- Drugs Celecoxib; LY 3031207
- Indications Arthritis; Pain
- Focus Adverse reactions
- 16 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Apr 2012 Planned end date changed from 1 Mar 2012 to 1 Apr 2012 as reported by ClinicalTrials.gov.
- 10 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.